FDA Inspection 568746 — Savient Pharmaceuticals

Savient Pharmaceuticals — FEI 3000328745

The FDA completed an inspection of Savient Pharmaceuticals on Mar 6, 2009 in Bridgewater, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 6, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bridgewater, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.